| Clinical data | |
|---|---|
| Drug class | Progestin;Progestogen |
| Identifiers | |
| CAS Number | |
| PubChem SID | |
ORG-201745 is aprogestin which was originated byOrganon and was under development bySchering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as ahormonal contraceptive for the prevention ofpregnancy but was never marketed.[1]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |